- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
OMAPiX Inc
OMAPiX Inc is listed as a new startup research supplier in the Scientist.com network, with 2 sites in 1 country.
View OMAPiX Inc on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
2
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: New startup
Antibodies
- Antibody-Drug Conjugation Improve therapeutic properties of an antibody or drug by joining them together.
Biomarkers
- Biomarker Analytical Validation Assess and optimize the characteristics of a candidate biomarker to ensure reproducibility and consistency.
- Biomarker Clinical Utility Evaluate the potential clinical applications of a candidate biomarker.
- Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
- Biomarker Services Evaluating normal/abnormal biological conditions and characteristics within the body
- Diagnostic Biomarkers Discovery Identify candidate biomarkers indicative of the presence of a disorder.
- Fluorescent In Situ Hybridization Use FISH to identify abnormal chromosome structures and to quantify specific DNA sequences.
Show all 15 in Biomarkers
- Immunohistochemistry Examine the toxic effects of pre-clinical compounds in small animal and patient histological samples.
- Immunostaining Use labeled antibodies to detect proteins or other antigens in cells or tissues.
- Multi-Omics Study Use an integrated multi-omics study to understand a disease mechanism.
- Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
- Predictive Biomarkers Discovery Identify candidate biomarkers suggestive of a response to a treatment.
- Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.
- Single Cell Transcriptome Sequencing Detect distinct, rare or abnomal cell types in a heterogenous population.
- Solid Tumor CDx Design and validate companion diagnostics for solid tumors that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
- Stem Cell Analysis Assess hematopoietic, neural and mesenchymal cell progenitor proliferation and differentiation.
Cell Culture and Characterization
- Single Cell Services Request services to perform genomics, transcriptomics, proteomics, metabolomics and cell–cell interactions at the single cell level
Data Science/Bioinformatics
- Clinical Biomarker Analysis An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.
- Discovery Biomarker Analytics An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.
- Discovery Data Analysis Analysis that helps you make sense of your discovery data
- Discovery Omics Analytics A process to analyze various omics data (genomics, transcriptomics, proteomics, metabolomics, etc.) This can include the integration of different omics data. Helps to better understand the molecular environment...
- Translational Biomarker Discovery An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.
- Translational In Silico Genomics/Transcriptomics Data Analysis A process that helps make sense of your omics data
Show all 7 in Data Science/Bioinformatics
- Translational Omics Analytics A process to analyze various omics data (genomics, transcriptomics, proteomics, metabolomics, etc.) This can include the integration of different omics data. Helps to better understand the molecular environment...
Show all 50 services
Disease Models
- Neuroscience Models Test therapeutic efficacy of drug candidate in neurological disease model.
DNA & RNA
- NGS: Next Generation Sequencing Sequence millions of template DNA molecules in parallel.
- RNA Profiling Quantify the expression levels of mRNA transcripts, enabling the determination of gene expression patterns.
- RNA Sequencing Use Next Generation Sequencing techniques to Identify RNA transcripts, examine differential expression patterns and analyze splice variants.
- RNA Sequencing/Resequencing Identify RNA transcripts, examine differential expression patterns and analyze splice variants.
- RNAseq and DNAseq library preparation and sequencing DNA/RNA sequencing and preparations
- Single Cell RNA Sequencing Quantify mRNA variants in a single cell.
Show all 9 in DNA & RNA
- Targeted Sequencing/Resequencing Detect variations in a genome subset.
- TCR Repertoire Sequencing Analyze the T cell receptor repertoire by means of next-generation sequencing.
- Total RNA Sequencing Identify novel RNA transcripts and detect gene expression changes.
Human Biological Samples
- Human Organoids Test immuno-oncology drugs and therapies on fresh, unpropagated 3D tumor organoids to evaluate efficacy and understand drug mechanism of action. Understand the intact tumor immune microenvironment, cytotoxic efficacy...
In Vitro Pharmacology
- Immuno-oncology Targets Develop drugs that take advantage of the immune system to target cancer cells.
Oncology Models
- Immuno-PDX Utilize the patient-derived xenograft for drug response profiling and biomarker discovery of immuno-oncology drug candidates.
- Oncology Derived PDX Patient derived xenografts derived from various oncological samples. This includes, but is not limited to, samples from Lymphoma, Melanoma, and Leukemia.
- Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
- Oncology Xenografts Xenografts derived from oncological samples.
- Xenograft Models Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.
Other Specialty Toxicology
- Tumorigenicity Testing Test tumor-forming properties of cell products.
Protein Sciences
- Proteomics Do large-scale experimental analysis of proteins focused on understanding structure and function.
Real World Evidence & Data
- RWD - Genomics Genomic data collected from a patients with different diseases, can be derived from a range of sources.
- RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
Scientific Data Services
- Bioinformatics Bioinformatics is a powerful method of storing, retrieving and analyzing biological data.
- Cancer Systems Biology Convert complex molecular data obtained from high-throughput technologies to deducible information.
- Marker Analyses Identify associations between genetic markers and traits of interest to determine markers responsible for human diseases.
- NGS: Next Generation Sequencing Data Analysis Use software to interpret data created by RNA-Seq, DNA-Seq, ChIP-Seq and DNA methylation experiments.
- Omics Informatics Consulting Services for the analysis of large-scale molecular data sets.
- Website
- www.omapix.com
Where it operates
Sites by country, with the cities in each.
-
United States 2 sites
Work with OMAPiX Inc on Scientist.com
For prices, more details, or to contact OMAPiX Inc, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.